If we also incorporated evidence-based treatment at discharge and reperfusion therapy in the multivariable adjustments, there was no longer a significant gender difference in long-term mortality.
Following multivariable adjustments, there was a stepwise increase in mortality with increasing quartiles of NLR (first quartile: reference category; second quartile odds ratio (OR) = 1.32; 95% confidence interval (CI), 1.03 to 1.71; third quartile OR = 1.43; 95% CI, 1.12 to 1.83; 4th quartile OR = 1.71; 95% CI, 1.35 to 2.16).
After multivariable adjustment including eGFR, there was no longer any gender difference in early outcome and the long-term outcome was better in women.
However, after multivariable adjustment and matched pair analysis there were no differences in ICU or hospital mortality rates between High or LowABR ICU patients overall or among those with infections.
However, after multivariable adjustment for the potential confounders, there was no significant association of the quintiles of NAEes with presence of albuminuria.
After multivariable adjustment, including body size (model 3), there was a positive association of the lipophilic index with fetuin-A in men (p for trend across quartiles <0.001) and a slight positive association with HDL-cholesterol in women (p = 0.002).
There was no association between B12 and incident RKF after multivariable adjustment either before (OR 0.99, 95% CI 0.69-1.53) or after baseline homocysteine adjustment (OR 1.32, 95% CI 0.87 – 2.0.87
There were no significant associations between flavonoids and CHD incidence after multivariable adjustment.
There was no association between B12 levels and incident albuminuria after multivariable adjustment (OR 0.96, 95% CI 0.66-1.39, Table 3) or after further adjustment for baseline homocysteine levels (OR 1.17, 95% CI 0.79 – 1.73, Table 3).
